Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Clark

Showing results (201-210 of 210) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 210 results.
Journal of Neurology, Neurosurgery, and Psychiatry|February 1, 1996
Comparison of positron emission tomography, cognition, and brain volume in Alzheimer's disease with and without severe abnormalities of white matterC DeCarli, C L Grady, C M Clark, et al.
Neurology|October 5, 2007
Corticobasal syndrome and primary progressive aphasia as manifestations of LRRK2 gene mutationsA S Chen-Plotkin, W Yuan, C Anderson, et al.
Archives of Neurology|July 25, 1998
High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotypeD Galasko, L Chang, R Motter, et al.
Neurology|November 5, 2010
Novel CSF biomarkers for frontotemporal lobar degenerationsW T Hu, A Chen-Plotkin, M Grossman, et al.
Neurology|April 18, 2007
Cognitive and motor assessment in autopsy-proven corticobasal degenerationR Murray, M Neumann, M S Forman, et al.
Neurobiology of Aging|January 4, 2011
Amyloid precursor protein (APP) processing genes and cerebrospinal fluid APP cleavage product levels in Alzheimer's diseaseL M Bekris, N M Galloway, S Millard, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 7, 2007
Factors associated with survival probability in autopsy-proven frontotemporal lobar degenerationS X Xie, M S Forman, J Farmer, et al.
Neurobiology of Aging|August 30, 2005
Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairmentM J de Leon, S DeSanti, R Zinkowski, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 8, 2009
Neuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer's diseaseM Britschgi, C E Olin, H T Johns, et al.
JAMA|November 22, 2001
Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcomeD H Silverman, G W Small, C Y Chang, et al.
Pageof 21

Showing results (201-210 of 210) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 210 results.
Journal of Neurology, Neurosurgery, and Psychiatry|February 1, 1996
Comparison of positron emission tomography, cognition, and brain volume in Alzheimer's disease with and without severe abnormalities of white matterC DeCarli, C L Grady, C M Clark, et al.
Neurology|October 5, 2007
Corticobasal syndrome and primary progressive aphasia as manifestations of LRRK2 gene mutationsA S Chen-Plotkin, W Yuan, C Anderson, et al.
Archives of Neurology|July 25, 1998
High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotypeD Galasko, L Chang, R Motter, et al.
Neurology|November 5, 2010
Novel CSF biomarkers for frontotemporal lobar degenerationsW T Hu, A Chen-Plotkin, M Grossman, et al.
Neurology|April 18, 2007
Cognitive and motor assessment in autopsy-proven corticobasal degenerationR Murray, M Neumann, M S Forman, et al.
Neurobiology of Aging|January 4, 2011
Amyloid precursor protein (APP) processing genes and cerebrospinal fluid APP cleavage product levels in Alzheimer's diseaseL M Bekris, N M Galloway, S Millard, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 7, 2007
Factors associated with survival probability in autopsy-proven frontotemporal lobar degenerationS X Xie, M S Forman, J Farmer, et al.
Neurobiology of Aging|August 30, 2005
Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairmentM J de Leon, S DeSanti, R Zinkowski, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 8, 2009
Neuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer's diseaseM Britschgi, C E Olin, H T Johns, et al.
JAMA|November 22, 2001
Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcomeD H Silverman, G W Small, C Y Chang, et al.
Pageof 21